Orchestra Biomed Holdings vs Retractable Technologies
Orchestra Biomed Holdings and Retractable Technologies are similar in size: $33.5m and $38.3m of revenue in their latest fiscal years. Orchestra Biomed Holdings grew faster (1169.2% against 15.8%). Retractable Technologies kept more of each dollar of sales as profit: a net margin of -32.8% against -157.4%.
| Latest fiscal year | Orchestra Biomed HoldingsOBIO, 2025 | Retractable TechnologiesRVP, 2025 |
|---|---|---|
| Revenue | $33.5m | $38.3m |
| Revenue growth | 1169.2% | 15.8% |
| Net income | −$52.7m | −$12.6m |
| Operating margin | — | -55.3% |
| Net margin | -157.4% | -32.8% |
| Return on equity | -121.8% | -15.6% |
| Free cash flow | −$49.5m | −$7.1m |
| Cash | $34.7m | $2.6m |
| Total debt | $15.0m | $895,645 |
| Debt to equity | — | 1.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 86 | 201 |
| Market value | $338m | $16.9m |
| Price vs our value range | — | — |
| Moat score | — | 30 (Weak) |
| Insider trades, 12 months | 9 buys, 6 sales | 3 buys, 0 sales |